Meeting
2019 ASCO Annual Meeting
Genomic alterations after EGFR blockade in patients with RAS wild-type metastatic colorectal cancer: Combined tissue and blood-based analysis from SCRUM-Japan GI-SCREEN and GOZILA.
Authors
Yoshiaki Nakamura
Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
Yoshiaki Nakamura , Riu Yamashita , Wataru Okamoto , Yukiya Narita , Yoshito Komatsu , Yoshinori Kagawa , Naoki Takahashi , Taito Esaki , Takeshi Kato , Yu Sunakawa , Tadamichi Denda , Tomohiro Nishina , Atsuo Takashima , Takaaki Kobayashi , Manabu Shiozawa , Eiji Oki , Taroh Satoh , Yuta Adachi , Justin Odegaard , Takayuki Yoshino
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3528)
DOI
10.1200/JCO.2019.37.15_suppl.3528
Abstract #
3528
Poster Bd #
20
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2014 ASCO Annual Meeting
Implementation of clinical next-generation sequencing (NGS) of non-small cell lung cancer (NSCLC) to identify EGFR amplification as a potentially targetable oncogenic alteration.
First Author: Geoffrey R. Oxnard